On 28 November 2014
IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 November 2014, to consider and approve the Conversion of FCCBs into equity shares, un-audited financial results of the Company for the quarter and half year ended 30 September 2014 and to constitute a Committee to consider joint venture(s), restructuring etc to unleash the potential of the Company.Powered by Capital Market - Live News